R&D Pipeline
2 compounds matching your criteria
| Compound/indication | Phase 1 | Phase 2 | Phase 3 | Filed | |||
| Vagifem® Hormone replacement therapy |  |
||||||
| Liraglutide as anti-obesity agent Obese, non-diabetic people |  |
||||||
| Compound/indication | Phase 1 | Phase 2 | Phase 3 | Filed | |||
| Vagifem® Hormone replacement therapy | |
||||||
| Liraglutide as anti-obesity agent Obese, non-diabetic people | |
||||||
